The brain-derived neurotrophic factor (BDNF) has received considerable attention as a
potential biomarker of major depressive disorder (MDD) and antidepressant response. We …

The interest in psilocybin as a therapeutic approach has grown exponentially in recent
years. Despite increasing access, there remains a lack of practical guidance on the topic for …

Background: Depression is a mental disorder that poses a serious threat to human health.
Adult hippocampal neurogenesis (AHN) is closely associated with the efficacy of …

Abstract N6-methyladenosine (m6A) is a dynamic reversible methylation modification of the
adenosine N6 position and is the most common chemical epigenetic modification among …

Depression is the most prevalent mental disorder in the world associated with huge socio-
economic consequences. While depressive-related symptoms are well known, the …

Brain-derived neurotrophic factor (BDNF) belongs to the family of neurotrophins, which are
growth factors with trophic effects on neurons. BDNF is the most widely distributed …

Depression is the most common and devastating psychiatric disorder in the world. Its
symptoms, especially during the pandemic, are observed in all age groups. Exercise training …

Omega-3 polyunsaturated fatty acids have received considerable attention in the field of
mental health, in particular regarding the treatment of depression. This review presents an …

Background: In major depressive disorder (MDD), cognitive dysfunctions strongly contribute
to functional impairments but are barely addressed in current therapies. Novel treatment …

Depression is an overwhelming health concern, and many patients fail to optimally respond
to available standard therapies. Neuroplasticity and blood–brain barrier (BBB) integrity are …